FINWIRES · TerminalLIVE
FINWIRES

Roivant Sciences Insider Sold Shares Worth $6,631,268, According to a Recent SEC Filing

By

Eric Venker, President & Immunovant Chief Executive Officer, on June 24, 2026, sold 200,000 shares in Roivant Sciences (ROIV) for $6,631,268. Following the Form 4 filing with the SEC, Venker has control over a total of 1,613,063 common shares of the company, with 1,613,063 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000163508826000071/xslF345X05/wk-form4_1782512028.xml

Related Articles